Clinical Trial Update: To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating JT-001 add-on therapy in adults with type 2 diabetes mellitus inadequately controlled with metformin and dapagliflozin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• JT-001

Snippet

Sponsor: Jeil Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: UNKNOWN